StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Triethylamine → (2S)-1-{(2R)-4-[2-(2-Aminopyrimidin-5-yl)-9-isobutyl-6-morpholin-4-yl-9H-purin-8-yl]-2-methylpiperazin-1-yl}-1-oxopropan-2-ol

HRID 1876597
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1876597
[C:1]([OH:6])(=O)[C@H:2]([CH3:4])[OH:3].O.ON1C2C=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C.C(N(CC)CC)C.[CH2:37]([N:41]1[C:49]([N:50]2[CH2:55][CH2:54][NH:53][C@H:52]([CH3:56])[CH2:51]2)=[N:48][C:47]2[C:42]1=[N:43][C:44]([C:63]1[CH:64]=[N:65][C:66]([NH2:69])=[N:67][CH:68]=1)=[N:45][C:46]=2[N:57]1[CH2:62][CH2:61][O:60][CH2:59][CH2:58]1)[CH:38]([CH3:40])[CH3:39]>C(Cl)Cl.CO.CN(C)C=O>[NH2:69][C:66]1[N:65]=[CH:64][C:63]([C:44]2[N:43]=[C:42]3[C:47]([N:48]=[C:49]([N:50]4[CH2:55][CH2:54][N:53]([C:1](=[O:6])[C@@H:2]([OH:3])[CH3:4])[C@H:52]([CH3:56])[CH2:51]4)[N:41]3[CH2:37][CH:38]([CH3:39])[CH3:40])=[C:46]([N:57]3[CH2:62][CH2:61][O:60][CH2:59][CH2:58]3)[N:45]=2)=[CH:68][N:67]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

8

Edukt 5

HCID 8471Triethylamine3×HCID 107689L-Lactic Acid3×HCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride3×HCID 27960291-Hydroxybenzotriazole hydrate2×HCID 593335435-{9-Isobutyl-8-[(3R)-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amine

Produkt

1
HCID 59333564(2S)-1-{(2R)-4-[2-(2-Aminopyrimidin-5-yl)-9-isobutyl-6-morpholin-4-yl-9H-purin-8-yl]-2-methylpiperazin-1-yl}-1-oxopropan-2-olAusbeute 50 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 21226129Dichloromethane methanolLösungsmittel2×

Versuchsvorschrift

L-Lactic acid (25.9 μl, 0.29 mmol), 1-hydroxybenzotriazole monohydrate (37.6 mg, 0.25 mmol), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (70.5 mg, 0.37 mmol), and triethylamine (51.3 μl, 0.37 mmol) were added to an N,N-dimethylformamide solution (2.0 ml) of 5-{9-isobutyl-8-[(3R)-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amine (111.0 mg, 0.25 mmol) at room temperature. The resulting mixture was stirred for 2 days followed by the addition of L-lactic acid (25.9 μl, 0.29 mmol), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (70.5 mg, 0.37 mmol), and triethylamine (51.3 μl, 0.37 mmol). The resulting mixture was stirred for 25 hours and the reaction mixture was poured into methylene chloride-methanol (10:1), washed with saturated aqueous sodium hydrogen carbonate solution, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure and the resulting residue was dissolved in methylene chloride (3.0 ml) followed by the addition of L-lactic acid (25.9 μl, 0.29 mmol), 1-hydroxybenzotriazole monohydrate (37.6 mg, 0.25 mmol), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (70.5 mg, 0.37 mmol), and triethylamine (51.3 μl, 0.37 mmol) at room temperature. The resulting mixture was stirred for 18 hours and then the reaction mixture was poured into methylene chloride-methanol (10:1), washed with saturated aqueous sodium hydrogen carbonate solution, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure and the resulting residue was purified by preparative thin layer silica gel chromatography (methylene chloride:methanol=10:1) to give the title compound (64.8 mg, 50%) as a pale yellow solid.

Aufarbeitung

  1. stirringThe resulting mixture was stirred for 25 hours
  2. washwashed with saturated aqueous sodium hydrogen carbonate solution
  3. dry with materialdried over anhydrous sodium sulfate
  4. filtrationAfter filtration
  5. concentrationthe filtrate was concentrated under reduced pressure
  6. dissolutionthe resulting residue was dissolved in methylene chloride (3.0 ml)
  7. stirringThe resulting mixture was stirred for 18 hours
  8. washwashed with saturated aqueous sodium hydrogen carbonate solution
  9. dry with materialdried over anhydrous sodium sulfate
  10. filtrationAfter filtration
  11. concentrationthe filtrate was concentrated under reduced pressure
  12. customthe resulting residue was purified by preparative thin layer silica gel chromatography (methylene chloride:methanol=10:1)

Quellen und Nachweise

ORD-Eintrag
ord-e8f247c18f424620bd4adea94dfba166
Quelldatensatz
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08309546B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion